Area of research
Biomaterials · Molecular Biology
Research interest
Research interests include Cancer research, Materials science, Medicine, Doxorubicin, Chemistry, and Nanoparticle.
Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
CADD-03. A VERSATILE AND MODULAR TARGETED NANOPARTICLE PLATFORM FOR DELIVERY OF COMBINATION THERAPIES TO ADULT AND PEDIATRIC CNS TUMORS
Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle
A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging
A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
Bimodal Tumor-Targeting from Microenvironment Responsive Hyaluronan Layer-by-Layer (LbL) Nanoparticles
Layer-by-Layer Assembled Antisense DNA Microsponge Particles for Efficient Delivery of Cancer Therapeutics
FRET-enabled biological characterization of polymeric micelles
PEG–Polypeptide Block Copolymers as pH-Responsive Endosome-Solubilizing Drug Nanocarriers
A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
DSpace@MIT (Massachusetts Institute of Technology) 2014cited by 0position: first
Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
Surface-Mediated Bone Tissue Morphogenesis from Tunable Nanolayered Implant Coatings
RNAi‐Microsponges Form through Self‐Assembly of the Organic and Inorganic Products of Transcription
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)
The architecture and biological performance of drug-loaded LbL nanoparticles
Fluorescent Multiblock Ï-Conjugated Polymer Nanoparticles for In Vivo Tumor Targeting